SERPINB5 is less well known; its transcript was decreased in PCa samples in this study, which would fit with its role in tumour inhibition, with loss or decreased expression of SERPINB5 being reported in prostate cancer cells [49]. This evidence concerns the gene SERPINB5 and posterior cortical atrophy.